Home  

Random  

Nearby  



Log in  



Settings  



Donate  



About Wikipedia  

Disclaimers  



Wikipedia





Cyclizine





Article  

Talk  



Language  

Watch  

Edit  





Cyclizine, sold under a number of brand names, is a medication used to treat and prevent nausea, vomiting and dizziness due to motion sicknessorvertigo.[2] It may also be used for nausea after general anaesthesia or that which developed from opioid use.[2][3] It is taken by mouth, in the rectum, or injected into a vein.[3][4]

Cyclizine
Clinical data
Trade namesMarezine, Valoid, Nausicalm, others
AHFS/Drugs.comConsumer Drug Information
Pregnancy
category
  • AU:A
  • Routes of
    administration
    By mouth, IM, IV
    ATC code
    Legal status
    Legal status
    • AU: S3 (Pharmacist only)
  • UK: P (Pharmacy medicines)
  • US: OTC
  • OTC (Netherlands)
  • Pharmacokinetic data
    MetabolismN-demethylated to inactive norcyclizine[1]
    Elimination half-life20 hours
    Identifiers
    • 1-benzhydryl-4-methyl-piperazine

    CAS Number
    PubChem CID
    IUPHAR/BPS
    DrugBank
    ChemSpider
    UNII
    KEGG
    ChEBI
    ChEMBL
    CompTox Dashboard (EPA)
    ECHA InfoCard100.001.314 Edit this at Wikidata
    Chemical and physical data
    FormulaC18H22N2
    Molar mass266.388 g·mol−1
    3D model (JSmol)
    • CN(CC1)CCN1C(C2=CC=CC=C2)C3=CC=CC=C3

    • InChI=1S/C18H22N2/c1-19-12-14-20(15-13-19)18(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18H,12-15H2,1H3 checkY

    • Key:UVKZSORBKUEBAZ-UHFFFAOYSA-N checkY

      (verify)

    Common side effects include sleepiness, dry mouth, constipation, and trouble with vision.[5] More serious side effects include low blood pressure and urinary retention.[5] It is not generally recommended in young children or those with glaucoma.[2][6] Cyclizine appears to be safe during pregnancy but has not been well studied.[7] It is in the anticholinergic and antihistamine family of medications.[3][6]

    Cyclizine was discovered in 1947.[8] It is on the World Health Organization's List of Essential Medicines.[9] In the United States it is available over the counter.[6]

    Medical uses

    edit

    Primary uses include nausea, vomiting and dizziness associated with motion sickness, vertigo and post-operatively following administration of general anesthesia and opioids. It is sometimes given in hyperemesis gravidarum, although the manufacturer advises that it be avoided in pregnancy. Off-license use often occurs with specialists in hospitals to treat inpatients who have become severely dehydrated in pregnancy. An off-label use is as an opioid/opiate potentiator.[10]

    The drug Diconal is a combination of cyclizine and the opioid dipipanone.[11] Dipipanone is a schedule I controlled substance in the US.[12]

    Contraindications

    edit

    Its antimuscarinic action warrants caution in patients with prostatic hypertrophy, urinary retention, or angle-closure glaucoma. Liver disease exacerbates its sedative effects.[10]

    Adverse effects

    edit

    Common (over 10%) — Drowsiness, dry mouth.

    Uncommon (1% to 10%) — Headache, psychomotor impairment, dermatitis, and antimuscarinic effects such as diplopia (double vision), tachycardia, constipation, urinary retention and gastro-intestinal disturbances.

    Rare (less than 1%) — Hypersensitivity reactions (bronchospasm, angioedema, anaphylaxis, rashes and photosensitivity reactions), extrapyramidal effects, dizziness, confusion, depression, sleep disturbances, tremor, liver dysfunction, and hallucinations.

    Pharmacology

    edit

    Cyclizine is a piperazine derivative with histamine H1-receptor antagonist (antihistamine) activity. The precise mechanism of action in inhibiting the symptoms of motion sickness is not well understood. It may have effects directly on the vestibular system and on the chemoreceptor trigger zone. Cyclizine exerts a central anticholinergic (antimuscarinic) action.[10]

    Synthesis

    edit

    Cyclizine may be prepared by the Eschweiler–Clarke methylationofdiphenylmethylpiperazine or by reaction of benzhydryl bromide with 1-methylpiperazine in acetonitrile to form the hydrobromide salt of the drug.

    History

    edit

    Cyclizine was developed in the American division of pharmacy company Burroughs Wellcome (today GlaxoSmithKline) during a research study involving many drugs of the antihistamine group. Cyclizine was quickly clinically found as a potent and long-acting antiemetic. The company named the substance – or more precisely cyclizine's hydrochloride form which it usually appears in – "marezine hydrochloride" and started to sell it in the United States under trade name Marezine. Selling was begun in France under trade name Marzine in 1965.[13][14]

    The substance received more credit when NASA chose it as a space antiemetic for the first crewed Moon flight. Cyclizine was introduced to many countries as a common antiemetic. It is an over-the-counter drug in many countries because it has been well tolerated, although it has not been studied much.[13][15]

    Society and culture

    edit

    Some people using methadone recreationally combine cyclizine with their methadone dose, a combination that is known to produce strong psychoactive effects.[16] It has also been used recreationally for its anticholinergic effects to induce hallucinations.[17]

    It has been used illegally in greyhound racing to sabotage a dog's performance.[18]

    Names

    edit

    As cyclizine hydrochloride tablets and cyclizine lactate solution for intramuscular or intravenous injection (brand names: Valoid[10] in UK and South Africa and Marezine, Marzine and Emoquil in US). Cyclizine was marketed as Bonine for Kids in the US, but was discontinued in 2012, and replaced with meclizine.[19]

    Cyclizine derivatives

    edit
    Structural comparison of cyclizine
    and related H1 antagonists[20]
     
    Compound R1 R2
    Cyclizine H CH3
    Chlorcyclizine Cl CH3
    Meclizine Cl  
    Buclizine Cl  
    Oxatomide H  
    Hydroxyzine Cl  
    Cetirizine Cl  

    See also

    edit

    References

    edit
    1. ^ "DrugBank: Cyclizine. Pharmacology: metabolism". DrugBank Database. Archived from the original on 30 January 2016. Retrieved 5 January 2016.
  • ^ a b c "Cyclizine 50mg Tablets - Summary of Product Characteristics (SPC) - (eMC)". www.medicines.org.uk. 27 March 2015. Archived from the original on 20 December 2016. Retrieved 13 December 2016.
  • ^ a b c Feldman M, Friedman LS, Brandt LJ (2015). Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. Elsevier Health Sciences. p. 218. ISBN 9781455749898. Archived from the original on 20 December 2016.
  • ^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  • ^ a b "Cyclizine Side Effects in Detail - Drugs.com". www.drugs.com. Archived from the original on 21 December 2016. Retrieved 13 December 2016.
  • ^ a b c "Cyclizine: Indications, Side Effects, Warnings - Drugs.com". www.drugs.com. Archived from the original on 21 December 2016. Retrieved 13 December 2016.
  • ^ "Cyclizine Use During Pregnancy | Drugs.com". www.drugs.com. Archived from the original on 21 December 2016. Retrieved 13 December 2016.
  • ^ Williams P (2010). The story of the Wellcome Trust : unlocking Sir Henry's legacy to medical research. Hindringham: JJG. p. 14. ISBN 9781899163922. Archived from the original on 20 December 2016.
  • ^ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
  • ^ a b c d "Valoid Tablets by Amdipharm". Electronic Medicines Compendium. Datapharm. Archived from the original on 4 March 2016. Retrieved 1 October 2011.
  • ^ "Diconal Tablets by Amdipharm". Electronic Medicines Compendium. Datapharm. Archived from the original on 1 April 2008. Retrieved 5 August 2008.
  • ^ "Conversion Factors for Controlled Substances". DEA Diversion Control Division. Retrieved 26 March 2020.
  • ^ a b Sneader W (2005). Drug discovery: a history. John Wiley & Sons. p. 404. ISBN 0-471-89979-8. Archived from the original on 10 September 2017.
  • ^ Sittig M (1988). Pharmaceutical manufacturing encyclopedia. William Andrew. p. 406. ISBN 0-8155-1144-2. Archived from the original on 10 September 2017.
  • ^ Rajoo SG. "Introduction". In Lobo M (ed.). Anti-emetics - Metoclopramide, Domperidone, Ondansetron, Cyclizine. Archived from the original on 2 April 2015. Retrieved 9 March 2015. {{cite book}}: |work= ignored (help)
  • ^ Ruben SM, McLean PC, Melville J (August 1989). "Cyclizine abuse among a group of opiate dependents receiving methadone". British Journal of Addiction. 84 (8): 929–34. doi:10.1111/j.1360-0443.1989.tb00766.x. PMID 2775912.
  • ^ Bassett KE, Schunk JE, Crouch BI (September 1996). "Cyclizine abuse by teenagers in Utah". The American Journal of Emergency Medicine. 14 (5): 472–4. doi:10.1016/S0735-6757(96)90156-4. PMID 8765114.
  • ^ Conor Ryan for The Independent. June 20, 2013 IGB left with €250k bill after dog doping case Archived 2016-03-04 at the Wayback Machine
  • ^ "Bonine for Kids". Insight Pharmaceuticals. Archived from the original on 17 September 2010.
  • ^ Lemke TL, Williams DA, Roche VF, Zito SW (2013). Foye's Principles of Medicinal Chemistry (7th ed.). Philadelphia: Wolters Kluwer Health / Lippincott Williams & Wilkins. p. 1056. ISBN 978-1-60913-345-0.
  • edit
    Retrieved from "https://en.wikipedia.org/w/index.php?title=Cyclizine&oldid=1234451639"




    Last edited on 14 July 2024, at 12:35  





    Languages

     


    العربية
    Cymraeg
    Dansk
    Deutsch
    Ελληνικά
    Español
    فارسی
    Français
    Հայերեն
    Bahasa Indonesia
    Italiano
    Jawa
    Magyar
    Minangkabau

    ି
    Polski
    Português
    Română
    Slovenščina
    Српски / srpski
    Srpskohrvatski / српскохрватски
    Sunda
    Suomi

    Türkçe
    Tiếng Vit

     

    Wikipedia


    This page was last edited on 14 July 2024, at 12:35 (UTC).

    Content is available under CC BY-SA 4.0 unless otherwise noted.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Terms of Use

    Desktop